Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer
2024 · Advanced Science · 7 citations
https://doi.org/10.1002/advs.202413514
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
10
Citations
2
h-index
0
i10-index
Yanzhi Zhang is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Traditional Chinese Medicine Analysis & Breast Cancer Treatment Studies & Thyroid Cancer Diagnosis and Treatment. The author has an h-index of 2, co-authored 6 publications.
https://doi.org/10.1002/advs.202413514
https://doi.org/10.1038/s41746-025-01927-1
Click to start Chat